查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1519387

2024-2032 年按癌症类型、技术（下一代定序、聚合酶链反应、免疫组织化学、原位杂交、微阵列等）、技术、应用和区域分類的癌症/肿瘤分析市场报告

Cancer/Tumor Profiling Market Report by Cancer Type, Technology (Next-Generation Sequencing, Polymerase Chain Reaction, Immunohistochemistry, In-Situ Hybridization, Microarray, and Others), Technique, Application, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 147 Pages | 商品交期: 2-3个工作天内

价格

2023 年，全球癌症/肿瘤分析市场规模达到 115 亿美元。

癌症/肿瘤分析，也称为生物标记测试，是指用于识别肿瘤组织样本中的特定蛋白质、基因或基因突变（变化）以及其他生物标记的实验室测试或程序。它帮助肿瘤学家确定患者肿瘤的途径是否与可用的标靶治疗相符。它还有助于常规诊断、治疗决策，以及根据个人疾病的严重程度和基因组构建制定个人化的治疗计划和疗法。癌症/肿瘤分析也广泛应用于个人化医疗、研究、生物标记的发现以及筛检和诊断技术的开发。

癌症/肿瘤分析市场趋势：

癌症/肿瘤分析广泛应用于药物设计、发现和开发过程中的肿瘤学研究和生物标记的发现。因此，癌症在全球的广泛流行是推动市场成长的主要因素。除此之外，对诊断和肿瘤分析的生物标记的日益关注以及大众对个人化医疗的偏好的转变正在增加产品需求。此外，政府对癌症研究的资助和支持也显着增加，以开发先进技术，以减少肿瘤检测和识别所需的时间。同时，分子生物学技术（例如下一代定序（NGS））的最新进展正在加速癌症/肿瘤分析的采用。此外，製药和生物技术公司为推出新疗法和新药物设计技术而增加对研发（R＆D）活动的​​投资正在推动市场成长。其他因素，包括临床试验数量的增加、免疫分析技术的日益采用、有利的报销政策、医疗基础设施的改善和技术进步，也为市场创造了积极的前景。

本报告回答的关键问题

  • 2023 年全球癌症/肿瘤分析市场规模有多大？
  • 2024-2032 年全球癌症/肿瘤分析市场的预期成长率是多少？
  • COVID-19 对全球癌症/肿瘤分析市场有何影响？
  • 推动全球癌症/肿瘤分析市场的关键因素是什么？
  • 根据癌症类型，全球癌症/肿瘤分析市场的细分如何？
  • 基于该技术的全球癌症/肿瘤分析市场的细分如何？
  • 全球癌症/肿瘤分析市场的关键区域有哪些？
  • 全球癌症/肿瘤分析市场的主要参与者/公司有哪些？

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 资料来源
    • 主要资源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球癌症/肿瘤分析市场

  • 市场概况
  • 市场业绩
  • COVID-19 的影响
  • 市场预测

第 6 章：市场区隔：依癌症类型

  • 乳癌
    • 市场走向
    • 市场预测
  • 肺癌
    • 市场走向
    • 市场预测
  • 大肠直肠癌
    • 市场走向
    • 市场预测
  • 摄护腺癌
    • 市场走向
    • 市场预测
  • 黑色素瘤
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 7 章：市场区隔：依技术

  • 新一代定序 (NGS)
    • 市场走向
    • 市场预测
  • 聚合酶炼式反应 (PCR)
    • 市场走向
    • 市场预测
  • 免疫组织化学 (IHC)
    • 市场走向
    • 市场预测
  • 原位杂交 (ISH)
    • 市场走向
    • 市场预测
  • 微阵列
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 8 章：市场区隔：依技术

  • 基因组学
    • 市场走向
    • 市场预测
  • 蛋白质体学
    • 市场走向
    • 市场预测
  • 表观遗传学
    • 市场走向
    • 市场预测
  • 代谢组学
    • 市场走向
    • 市场预测

第 9 章：市场区隔：按应用

  • 个人化医疗
    • 市场走向
    • 市场预测
  • 诊断
    • 市场走向
    • 市场预测
  • 生物标记发现
    • 市场走向
    • 市场预测
  • 预测
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 10 章：市场区隔：按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场走向
    • 市场细分：按国家/地区
    • 市场预测

第 11 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 12 章：价值链分析

第 13 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 14 章：价格分析

第15章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Abbott Laboratories
    • Becton Dickinson and Company
    • Caris Life Sciences
    • Exact Sciences Corporation
    • F. Hoffmann-La Roche Ltd
    • Hologic Inc.
    • HTG Molecular Diagnostics Inc.
    • Illumina Inc.
    • Laboratory Corporation of America Holdings
    • NeoGenomics Laboratories
    • Qiagen NV
    • Siemens AG
    • Sysmex Corporation
Product Code: SR112024A5231

The global cancer/tumor profiling market size reached US$ 11.5 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 24.6 Billion by 2032, exhibiting a growth rate (CAGR) of 8.6% during 2024-2032.

Cancer/tumor profiling, also known as biomarker testing, refers to a laboratory test or procedure used to identify specific proteins, genes or gene mutations (changes) and other biomarkers in a tumor tissue sample. It assists oncologists in determining if the pathways of a patient's tumor match up with the available targeted therapies. It also aids in routine diagnostics, therapeutic decision-making, and developing personalized treatment plans and therapies for individuals based on the severity of their ailment and genomic build-up. Cancer/tumor profiling also finds extensive applications in personalized medicine, research, the discovery of biomarkers, and the development of screening and diagnostic techniques.

Cancer/Tumor Profiling Market Trends:

Cancer/tumor profiling is widely used in oncology research and discovery of biomarkers during the process of drug design, discovery and development. As a result, the widespread prevalence of cancer across the globe represents the primary factor driving the market growth. Besides this, the growing focus on biomarkers for diagnosis and tumor profiling and the shifting preferences toward personalized medicine among the masses are augmenting the product demand. Additionally, there has been a significant rise in government funding and support for cancer research for the development of advanced techniques to reduce the time taken for the detection and identification of tumors. Along with this, the recent advancements in molecular biology techniques, such as next-generation sequencing (NGS), are accelerating the adoption of cancer/tumor profiling. Furthermore, the increasing investments by pharmaceutical and biotechnology companies in research and development (R&D) activities for the launch of novel therapies and new drug designing techniques are propelling the market growth. Other factors, including the rising number of clinical trials, growing adoption of immunoassay techniques, favorable reimbursement policies, improving healthcare infrastructure, and technological advancements, are also creating a positive outlook for the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global cancer/tumor profiling market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on cancer type, technology, technique and application.

Breakup by Cancer Type:

Breast Cancer

Lung Cancer

Colorectal Cancer

Prostate Cancer

Melanoma Cancer

Others

Breakup by Technology:

Next-Generation Sequencing (NGS)

Polymerase Chain Reaction (PCR)

Immunohistochemistry (IHC)

In-Situ Hybridization (ISH)

Microarray

Others

Breakup by Technique:

Genomics

Proteomics

Epigenetics

Metabolomics

Breakup by Application:

Personalized Medicine

Diagnostics

Biomarker Discovery

Prognostics

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Becton Dickinson and Company, Caris Life Sciences, Exact Sciences Corporation, F. Hoffmann-La Roche Ltd, Hologic Inc., HTG Molecular Diagnostics Inc., Illumina Inc., Laboratory Corporation of America Holdings, NeoGenomics Laboratories, Qiagen N.V., Siemens AG and Sysmex Corporation.

Key Questions Answered in This Report

  • 1. What was the size of the global cancer/tumor profiling market in 2023?
  • 2. What is the expected growth rate of the global cancer/tumor profiling market during 2024-2032?
  • 3. What has been the impact of COVID-19 on the global cancer/tumor profiling market?
  • 4. What are the key factors driving the global cancer/tumor profiling market?
  • 5. What is the breakup of the global cancer/tumor profiling market based on the cancer type?
  • 6. What is the breakup of the global cancer/tumor profiling market based on the technique?
  • 7. What are the key regions in the global cancer/tumor profiling market?
  • 8. Who are the key players/companies in the global cancer/tumor profiling market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Cancer/Tumor Profiling Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Cancer Type

  • 6.1 Breast Cancer
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Lung Cancer
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Colorectal Cancer
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Prostate Cancer
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Melanoma Cancer
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 Others
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast

7 Market Breakup by Technology

  • 7.1 Next-Generation Sequencing (NGS)
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Polymerase Chain Reaction (PCR)
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Immunohistochemistry (IHC)
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 In-Situ Hybridization (ISH)
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Microarray
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Others
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast

8 Market Breakup by Technique

  • 8.1 Genomics
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Proteomics
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Epigenetics
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Metabolomics
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Application

  • 9.1 Personalized Medicine
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Diagnostics
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Biomarker Discovery
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Prognostics
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast
  • 9.5 Others
    • 9.5.1 Market Trends
    • 9.5.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Abbott Laboratories
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 Becton Dickinson and Company
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3 Caris Life Sciences
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
    • 15.3.4 Exact Sciences Corporation
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
      • 15.3.4.4 SWOT Analysis
    • 15.3.5 F. Hoffmann-La Roche Ltd
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
    • 15.3.6 Hologic Inc.
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7 HTG Molecular Diagnostics Inc.
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
    • 15.3.8 Illumina Inc.
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 Laboratory Corporation of America Holdings
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 NeoGenomics Laboratories
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
    • 15.3.11 Qiagen N.V.
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials
      • 15.3.11.4 SWOT Analysis
    • 15.3.12 Siemens AG
      • 15.3.12.1 Company Overview
      • 15.3.12.2 Product Portfolio
      • 15.3.12.3 Financials
      • 15.3.12.4 SWOT Analysis
    • 15.3.13 Sysmex Corporation
      • 15.3.13.1 Company Overview
      • 15.3.13.2 Product Portfolio
      • 15.3.13.3 Financials
      • 15.3.13.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Cancer/Tumor Profiling Market: Major Drivers and Challenges
  • Figure 2: Global: Cancer/Tumor Profiling Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Cancer/Tumor Profiling Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Cancer/Tumor Profiling Market: Breakup by Cancer Type (in %), 2023
  • Figure 5: Global: Cancer/Tumor Profiling Market: Breakup by Technology (in %), 2023
  • Figure 6: Global: Cancer/Tumor Profiling Market: Breakup by Technique (in %), 2023
  • Figure 7: Global: Cancer/Tumor Profiling Market: Breakup by Application (in %), 2023
  • Figure 8: Global: Cancer/Tumor Profiling Market: Breakup by Region (in %), 2023
  • Figure 9: Global: Cancer/Tumor Profiling (Breast Cancer) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 10: Global: Cancer/Tumor Profiling (Breast Cancer) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 11: Global: Cancer/Tumor Profiling (Lung Cancer) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 12: Global: Cancer/Tumor Profiling (Lung Cancer) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 13: Global: Cancer/Tumor Profiling (Colorectal Cancer) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: Cancer/Tumor Profiling (Colorectal Cancer) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: Cancer/Tumor Profiling (Prostate Cancer) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: Cancer/Tumor Profiling (Prostate Cancer) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: Cancer/Tumor Profiling (Melanoma Cancer) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: Cancer/Tumor Profiling (Melanoma Cancer) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: Global: Cancer/Tumor Profiling (Other Cancer Types) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: Global: Cancer/Tumor Profiling (Other Cancer Types) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: Global: Cancer/Tumor Profiling (Next-Generation Sequencing-NGS) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: Global: Cancer/Tumor Profiling (Next-Generation Sequencing-NGS) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: Global: Cancer/Tumor Profiling (Polymerase Chain Reaction-PCR) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: Global: Cancer/Tumor Profiling (Polymerase Chain Reaction-PCR) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: Global: Cancer/Tumor Profiling (Immunohistochemistry-IHC) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: Global: Cancer/Tumor Profiling (Immunohistochemistry-IHC) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: Global: Cancer/Tumor Profiling (In-Situ Hybridization-ISH) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: Global: Cancer/Tumor Profiling (In-Situ Hybridization-ISH) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: Global: Cancer/Tumor Profiling (Microarray) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: Global: Cancer/Tumor Profiling (Microarray) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: Global: Cancer/Tumor Profiling (Other Technologies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: Global: Cancer/Tumor Profiling (Other Technologies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: Global: Cancer/Tumor Profiling (Genomics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: Global: Cancer/Tumor Profiling (Genomics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: Global: Cancer/Tumor Profiling (Proteomics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: Global: Cancer/Tumor Profiling (Proteomics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: Global: Cancer/Tumor Profiling (Epigenetics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: Global: Cancer/Tumor Profiling (Epigenetics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: Global: Cancer/Tumor Profiling (Metabolomics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: Global: Cancer/Tumor Profiling (Metabolomics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: Global: Cancer/Tumor Profiling (Personalized Medicine) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: Global: Cancer/Tumor Profiling (Personalized Medicine) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: Global: Cancer/Tumor Profiling (Diagnostics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: Global: Cancer/Tumor Profiling (Diagnostics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: Global: Cancer/Tumor Profiling (Biomarker Discovery) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: Global: Cancer/Tumor Profiling (Biomarker Discovery) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: Global: Cancer/Tumor Profiling (Prognostics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: Global: Cancer/Tumor Profiling (Prognostics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: Global: Cancer/Tumor Profiling (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: Global: Cancer/Tumor Profiling (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 51: North America: Cancer/Tumor Profiling Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 52: North America: Cancer/Tumor Profiling Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 53: United States: Cancer/Tumor Profiling Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: United States: Cancer/Tumor Profiling Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: Canada: Cancer/Tumor Profiling Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: Canada: Cancer/Tumor Profiling Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: Asia-Pacific: Cancer/Tumor Profiling Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: Asia-Pacific: Cancer/Tumor Profiling Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: China: Cancer/Tumor Profiling Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: China: Cancer/Tumor Profiling Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: Japan: Cancer/Tumor Profiling Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: Japan: Cancer/Tumor Profiling Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 63: India: Cancer/Tumor Profiling Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 64: India: Cancer/Tumor Profiling Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 65: South Korea: Cancer/Tumor Profiling Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 66: South Korea: Cancer/Tumor Profiling Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 67: Australia: Cancer/Tumor Profiling Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 68: Australia: Cancer/Tumor Profiling Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 69: Indonesia: Cancer/Tumor Profiling Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 70: Indonesia: Cancer/Tumor Profiling Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 71: Others: Cancer/Tumor Profiling Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 72: Others: Cancer/Tumor Profiling Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 73: Europe: Cancer/Tumor Profiling Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 74: Europe: Cancer/Tumor Profiling Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 75: Germany: Cancer/Tumor Profiling Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 76: Germany: Cancer/Tumor Profiling Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 77: France: Cancer/Tumor Profiling Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 78: France: Cancer/Tumor Profiling Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 79: United Kingdom: Cancer/Tumor Profiling Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 80: United Kingdom: Cancer/Tumor Profiling Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 81: Italy: Cancer/Tumor Profiling Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 82: Italy: Cancer/Tumor Profiling Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 83: Spain: Cancer/Tumor Profiling Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 84: Spain: Cancer/Tumor Profiling Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 85: Russia: Cancer/Tumor Profiling Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 86: Russia: Cancer/Tumor Profiling Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 87: Others: Cancer/Tumor Profiling Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 88: Others: Cancer/Tumor Profiling Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 89: Latin America: Cancer/Tumor Profiling Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 90: Latin America: Cancer/Tumor Profiling Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 91: Brazil: Cancer/Tumor Profiling Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 92: Brazil: Cancer/Tumor Profiling Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 93: Mexico: Cancer/Tumor Profiling Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 94: Mexico: Cancer/Tumor Profiling Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 95: Others: Cancer/Tumor Profiling Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 96: Others: Cancer/Tumor Profiling Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 97: Middle East and Africa: Cancer/Tumor Profiling Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 98: Middle East and Africa: Cancer/Tumor Profiling Market: Breakup by Country (in %), 2023
  • Figure 99: Middle East and Africa: Cancer/Tumor Profiling Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 100: Global: Cancer/Tumor Profiling Industry: SWOT Analysis
  • Figure 101: Global: Cancer/Tumor Profiling Industry: Value Chain Analysis
  • Figure 102: Global: Cancer/Tumor Profiling Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Cancer/Tumor Profiling Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Cancer/Tumor Profiling Market Forecast: Breakup by Cancer Type (in Million US$), 2024-2032
  • Table 3: Global: Cancer/Tumor Profiling Market Forecast: Breakup by Technology (in Million US$), 2024-2032
  • Table 4: Global: Cancer/Tumor Profiling Market Forecast: Breakup by Technique (in Million US$), 2024-2032
  • Table 5: Global: Cancer/Tumor Profiling Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 6: Global: Cancer/Tumor Profiling Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 7: Global: Cancer/Tumor Profiling Market: Competitive Structure
  • Table 8: Global: Cancer/Tumor Profiling Market: Key Players